[儿科患者对塞夫特里亚的过敏反应:挑战和管理]
María Rosina López-Forte1, Pablo Perea-Valle2
1Hospital Infantil de México Federico Gómez. mrlopez@ufm.edu.
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|October 2, 2025
概括
在儿童中诊断类素过敏是具有挑战性的. 皮肤测试和口腔挑战,就像青素G一样,对于准确识别过敏和在适当的时候安全地删除患者的标签至关重要.
科学领域:
- 儿科过敏和免疫学
- 临床药理学 临床药理学
- 药物过敏症 药物过敏症
背景情况:
- 素诱导的过敏反应很少见,但由于模糊的症状和有限的测试,在儿童中难以诊断.
- 青素G已经显示出诊断价值,特别是在口腔挑战中,提供高负预测价值.
- 基细胞激活试验 (BAT) 显示出诊断药物过敏的可变灵敏度.
研究的目的:
- 在儿科患者中调查疑似头素过敏的诊断方法.
- 评估皮肤测试和口腔挑战在治疗药物过敏的有用性.
主要方法:
- 一份病例报告显示,一名13岁的男孩在施用 ceftriaxone后出现过敏反应.
- 诊断工作包括基因细胞激活测试 (BAT),皮肤检测青素和化素,以及用阿莫西西林进行口服挑战.
- 治疗包括对急性症状给予上腺素和晶类药物.
主要成果:
- 对于 ceftriaxone 和 cefuroxime 的基激活测试是负的.
- 皮肤测试对青素和 cefuroxime 呈阴性,但对 ceftriaxone 呈阳性.
- 患者耐受了阿莫西西林的口服挑战,这表明了脱标的可能性.
结论:
- 临床医生应该利用特定抗生素的皮肤测试和口腔挑战来准确诊断药物过敏.
- 显著的百分比的儿科患者与类素过敏标签可以安全地使用适当的协议.
- 青素G皮肤测试和口服挑战对于指导疑似类素过敏患者安全选择抗生素至关重要.
相关概念视频
02:06Allergic Reactions
32.0K
Overview
32.0K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
01:26Tonsillitis II: Management
400
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
400
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
179
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
179
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
254
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K